Growth Guys Canada Semaglutide Lab Test Results

Anabolic Lab
December 30, 2024

Summary

The product Semaglutide, manufactured by Growth Guys Canada, underwent independent testing to verify its authenticity and potency. The sample, identified by batch number SG02, was submitted by Growth Guys Canada and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the presence of Semaglutide, with detected concentrations of 5.73 mg, 5.79 mg, and 5.76 mg, indicating a consistent and slightly elevated concentration across tested vials. The product’s purity was determined to be 99.420% to 99.262%, confirming its high quality.

The testing process began on 2 December 2024, with the sample received on 27 December 2024, and analysis completed on 30 December 2024. While the results confirm high purity and stable concentration, scrutiny of manufacturer-submitted samples remains essential to ensure reliability. Independent third-party testing remains critical to validate these findings comprehensively. This report serves as an educational resource to promote harm reduction and informed decision-making.


Detailed Report

Product Overview

  • Manufacturer: Growth Guys Canada
  • Product Name: Semaglutide
  • Active Ingredient: Semaglutide
  • Batch Number: SG02
  • Expiration Date: Not provided
  • Delivery Method: Viral Powder

Sample Acquisition and Testing

  • Task Number: #54918
  • Testing Ordered: 2 December 2024
  • Sample Received: 27 December 2024
  • Analysis Conducted By: Janoshik Analytical
  • Product Submitted By: Growth Guys Canada (Manufacturer)
  • Analysis Paid For By: Growth Guys Canada (Manufacturer)

Testing Results

  • Specification: 5 mg
  • Measured Concentration: 5.73 mg, 5.79 mg, 5.76 mg
  • Purity: 99.420%; 99.497%; 99.262%

Verification Details

Verification URL: https://janoshik.com/tests/54918_SB2C3PPUQAJW


Evaluation of Manufacturer-Submitted Testing

This analysis highlights the high potency and purity of the tested product, with minimal variation in concentration across tested vials. Since Growth Guys Canada submitted and funded the test, careful evaluation is needed to assess product consistency across different batches. While Janoshik Analytical is recognized for its transparency and rigorous testing protocols, these findings would benefit from independent validation through third-party testing across multiple samples.


Conclusion

The analysis confirms that Semaglutide from Growth Guys Canada maintains an exceptionally high purity of over 99.2%, with a measured concentration range of 5.73 mg to 5.79 mg, aligning well with expected potency. This batch exhibits strong quality control, but continued monitoring remains crucial to ensure consistency across production runs. This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding peptide products.


Disclaimer

This report is published for educational and harm reduction purposes. Manufacturer-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.

Leave the first comment

Growth Guys Canada Semaglutide Lab Test Results

Anabolic Lab
December 30, 2024

Summary

The product Semaglutide, manufactured by Growth Guys Canada, underwent independent testing to verify its authenticity and potency. The sample, identified by batch number SG02, was submitted by Growth Guys Canada and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the presence of Semaglutide, with detected concentrations of 5.73 mg, 5.79 mg, and 5.76 mg, indicating a consistent and slightly elevated concentration across tested vials. The product’s purity was determined to be 99.420% to 99.262%, confirming its high quality.

The testing process began on 2 December 2024, with the sample received on 27 December 2024, and analysis completed on 30 December 2024. While the results confirm high purity and stable concentration, scrutiny of manufacturer-submitted samples remains essential to ensure reliability. Independent third-party testing remains critical to validate these findings comprehensively. This report serves as an educational resource to promote harm reduction and informed decision-making.


Detailed Report

Product Overview

  • Manufacturer: Growth Guys Canada
  • Product Name: Semaglutide
  • Active Ingredient: Semaglutide
  • Batch Number: SG02
  • Expiration Date: Not provided
  • Delivery Method: Viral Powder

Sample Acquisition and Testing

  • Task Number: #54918
  • Testing Ordered: 2 December 2024
  • Sample Received: 27 December 2024
  • Analysis Conducted By: Janoshik Analytical
  • Product Submitted By: Growth Guys Canada (Manufacturer)
  • Analysis Paid For By: Growth Guys Canada (Manufacturer)

Testing Results

  • Specification: 5 mg
  • Measured Concentration: 5.73 mg, 5.79 mg, 5.76 mg
  • Purity: 99.420%; 99.497%; 99.262%

Verification Details

Verification URL: https://janoshik.com/tests/54918_SB2C3PPUQAJW


Evaluation of Manufacturer-Submitted Testing

This analysis highlights the high potency and purity of the tested product, with minimal variation in concentration across tested vials. Since Growth Guys Canada submitted and funded the test, careful evaluation is needed to assess product consistency across different batches. While Janoshik Analytical is recognized for its transparency and rigorous testing protocols, these findings would benefit from independent validation through third-party testing across multiple samples.


Conclusion

The analysis confirms that Semaglutide from Growth Guys Canada maintains an exceptionally high purity of over 99.2%, with a measured concentration range of 5.73 mg to 5.79 mg, aligning well with expected potency. This batch exhibits strong quality control, but continued monitoring remains crucial to ensure consistency across production runs. This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding peptide products.


Disclaimer

This report is published for educational and harm reduction purposes. Manufacturer-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.

Leave the first comment